Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions
|
|
- Jody Jennings
- 7 years ago
- Views:
Transcription
1 Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions Anna Sandström The Swedish Governmental Agency for Innovation Systems VINNOVA
2 Efficient innovation systems From idea to product and/or services VINNOVA s mission is to promote sustainable growth by developing effective innovation systems and financing problem-oriented research Innovation systems analyses and international benchmarking for national strategy development Interaction between Business Research Public Sector VINNOVA: about 170 employees and a budget of almost 140 MEuro 2006
3 Idea Product Service Private foundations (e.g. for specific diseases) Swedish Foundation for Strategic Research (strategic research, peer review but top down choice of areas) Swedish Research Council (basic research, peer review) VINNOVA (needs driven research and improved innovation systems) Innovation Bridge (seed financing, incubators) Swedish Industrial Development Fund (semi public VC) Venture Capital Companies Universities and the healthcare sector Life Science Industry
4 Development of a National Biotech Strategy Examples of analyses used as input to the process Industry Production Bibliometry Pipeline Interviews Workshops Dialogue Committee Strategy Political process Foresight
5 Strategy for growth Biotechnology World International alliances Sweden Academy Industry More effective commercialisation of science Strengthened excellent science base Internationally competitive business terms Increased knowledge, dialogue, cooperation and readiness Politics and society
6 variables
7 Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Broad R&D Narrow R&D Productdevelopment Consultancy Production Wtthout wtth without with product Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food NATIONAL MARKET (eg Malmoe/Lund) Region No. employees (eg ) INTERNATIONAL MARKET Category (eg production) Marketing & sales Region (eg Malmoe/Lund)
8 Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Cluster profile Sweden - Biotechnology, Pharmaceuticals and Medical Technology Broad R&D Narrow R&D Production Wtthout wtth without with product Marketing & sales Productdevelopment Consultancy Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food
9 Share of employees in different business segments employees in total Agrobiotech 1,3% Bioproduction 2,4% Biotech tools & supplies 9% Environmental biotech 0,1% Functional food 0,2% Medical technology 26% Drug discovery & development 48% CMO 2,9% CRO 1,8% Biotech medical technology 4,5% Diagnostics 3,0% Drug delivery 0,5%
10 No. employees in different categories Broad R&D with product Broad R&D + product Broad R&D Broad R&D/large pipeline yet without product 220 Narrow R&D with product Narrow R&D + product 750 Narrow R&D Narrow R&D yet without product 320 Own productdevelopment Product development Consultancy Konsult/CRO Production units in companies with R&D and with more than 500 employees. Production Marketing and sales Production Sales Produktionsenheter inom företag med mer än 500 anställda i Sverige och som även bedriver forskning och utveckling No. employees
11 Regional distribution of the Swedish Life Science industry Other parts of Sweden 3% Umeå 2% Gothenburg 19 % Stockholm/ Uppsala 58% Linköping 1% Malmoe/ Lund 17%
12 Development companies with employees Biotech firms Pharmacia related companies Astra/AstraZeneca No. Employees
13 Biotech + Astra/AstraZeneca & Pharmacia related companies 216 companies with employees (2003) Astra/AstraZeneca Pharmacia related companies Other biotech companies No. employees AstraZeneca Astra No. employees Biacore GE Healthcare Quintiles 7000 Amersham Bioscience Active Biotech Fresenius Kabi Pharmacia Biovitrum 4000 Octapharma Pharmacia 3000 Diagnostics Pfizer No.employees ,5 percent/year, Total + 38 percent Growth of the number of employees ,0 percent/year, Total + 19 percent + 6,2 percent/year, Total + 43 percent
14 Cluster Profile, SWEDEN Biotechnology, Pharmaceuticals Medical Technology (Excluding national market and marketing/sales) Broad R&D with product Broad R&D yet without prod Narrow R&D with product Narrow R&D yet without prod Own product development Consultancy Production Business segments: Drug discovery & development Drug delivery Diagnostics Biotech medical technology CRO Umeå Uppsala Stockholm Strängnäs Linköping Gothenburg Other Malmoe/Lund K10-BP1231 Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Medicon Valley Copenhagen
How To Compare Sweden To Danesland
Life science companies in Sweden Including a comparison with Denmark addendi Life science companies in Sweden - Including a comparison with Denmark Anna Sandström, VINNOVA Tage Dolk och Benny Dolk, Addendi
More informationFörhandskopia 2007 12 07
Förhandskopia 2007 12 07 Title: Biotechnology, pharmaceuticals and medical technology in Sweden 2007 - Cluster profiles Author: Anna Sandström and Helena Bergqvist, VINNOVA, Tage Dolk, Addendi AB Series:
More informationGlobala trender med lokala effekter
Globala trender med lokala effekter Den svenska Life Science industrin 1998-212 5 Mars kl. 8.3-1. Jenni Nordborg Göran Andersson Anna Sandström Life Sciences evolutionary and iterative innovation processes
More informationKarriärdagar Uppsala - Vad händer inom bioteknikbranschen?
The Swedish Biotechnology Industry Organization Karriärdagar Uppsala - Vad händer inom bioteknikbranschen? Uppsala karriärdagar March 15th, 2006 Per-Erik Sandlund SwedenBIO Wallingatan 24 SE-111 24 Stockholm
More informationLife science companies in Sweden Including a comparison with Denmark
VINNOVA ANALYSIS VA 2011:03 Life science companies in Sweden Including a comparison with Denmark Life science companies in Sweden Including a comparison with Denmark 0 addendi addendi Title: Life science
More informationThe Swedish Drug Development Pipeline. Dec. 2013. Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal
The Swedish Drug Development Pipeline & overview of companies with R&D activities in Sweden Dec. 2013 Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal
More informationThe Swedish Drug Development Pipeline 2014
The Swedish Drug Development Pipeline 2014 and an overview of swedish r&d companies 2013 december 2014 this report is compiled by swedenbio with support from vinnova 2 the swedish drug development pipeline
More informationThe Swedish Drug Development Pipeline. December 2013. & overview of Swedish companies with R&D activities in Sweden
The Swedish Drug Development Pipeline & overview of Swedish companies with R&D activities in Sweden December 2013 This report is compiled by SwedenBIO with support from VINNOVA and Business Sweden Table
More informationA Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute
A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy
More informationFor More Information
THE ARTS CHILD POLICY CIVIL JUSTICE EDUCATION ENERGY AND ENVIRONMENT This PDF document was made available from www.rand.org as a public service of the RAND Corporation. Jump down to document6 HEALTH AND
More informationOutsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation
More informationHow world-class diabetes research will contribute to Swedish growth
2013-04-05 How world-class diabetes research will contribute to Swedish growth A VINNOVA Innovation agenda April 2013 Karolinska Institutet Lund University Umeå University Uppsala University AstraZeneca
More information2013-03-04. Kurt Strömgren. Business coach - Uminova Innovation Manager Biotech Umeå. Ideas become business.
Kurt Strömgren Business coach - Uminova Innovation Manager Biotech Umeå Ideas become business. 1 The Umeå support system for innovations IDEA GROW EXPAND Innovationsslussen Entrepreneur center Uminova
More informationNew York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009
New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009 NYCEDC relationship to City Hall MAYOR Michael R. Bloomberg Deputy Mayor for Economic Development and Rebuilding
More informationTech transfer The Swedish Context. Academia-industry collaboration. .. Created the largest selling drug, LOSEC, followed by Nexium
Tech transfer The Swedish Context Claes Post, May 21 2010, Brussels Academia-industry collaboration Scand J Gastroenterol Suppl. 1989;166:3-11.The gastric H+,K+- ATPase: the site of action of omeprazole.sachs
More informationAn Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore
An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight
More informationA BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS
V I N N O V A A N A L Y S I S V A 2 0 0 8 : 1 2 A BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS Comparison of policies and funding U P P S A L A U N I V E R S I T Y V I
More informationCluster Formation Across Borders
Cluster Formation Across Borders Clusters in the Oresund Region by Torben Orla Nielsen Berlin November 13 th, 2007 Agenda The Region Øresund Science Region Status for Cluster Open Innovation Process Ambassador
More informationE- MARKETPLACES IN THE BIOTECH INDUSTRY
E- MARKETPLACES IN THE BIOTECH INDUSTRY By Jonas Bygdeson, Head of emarket Services Swedish Trade Council www.emarketservices.com May 2004 Abstract The purpose of this report is to study how electronic
More informationThe medical research situation in Sweden Preface
The medical research situation in Sweden Preface In cooperation with the six Swedish medical faculties, the Scientific Council for Medicine at the Swedish Research Council (SRC) appointed an inquiry group
More informationInfrastructure and users Public and private providers/users Issues and approaches Discussion
Henrik Hansson Department of Computer and Systems Sciences Stockholm University Sweden elearning Baltics Rostock 1 2 July 2010 Infrastructure and users Public and private providers/users Issues and approaches
More informationPerformance indicators, quality benchmarking and cost/ efficiency of emergency services. Gunnar Bergström SOS Alarm, Sweden
Performance indicators, quality benchmarking and cost/ efficiency of emergency services Gunnar Bergström SOS Alarm, Sweden SHORT INFO SOS Alarm is owned by the Government and the Swedish Association of
More informationSYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE 2015-02-06
SYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE 2015-02-06 AGENDA Welcome to SICS and INCOSE Sweden 10 min Purpose of WS 3 min Short presentation of everyone 15 min Background: The SoS Agenda project
More informationAchievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness
2015 Healthcare Healthcare Korea's healthcare industry is growing thanks to the advancement of the production infrastructure of pharmaceuticals, medical devices and cosmetics, support for healthcare-related
More informationCreative Force Eastern Europe and Western Balkans
Page: 1 (2) Creative Force Eastern Europe and Western Balkans Seed funding granted 2013-10-15 (Dnr 09476/2013) awarde d (in Kvinnofolkhögskol an Göteborg (10879/2013) SEK) Edumama Ukraine 30 130 Poppius
More informationFit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,
More informationJOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1
JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific
More informationEvent Sponsorship Opportunities
Event Sponsorship Opportunities Creating Value for Your Company Sponsoring Medicon Valley Alliance provides you with unique access to life science professionals in Denmark and Sweden. Through a range of
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?
More informationBusiness Incubation for Growth, BIG: A new national incubator program
Business Incubation for Growth, BIG: A new national incubator program Workshop on Innovation Policy in the Recession Birkbeck, London, 15 October 2012 Åsa Lindholm Dahlstrand CIRCLE Lund University, Sweden
More informationPDP Funders Group Briefing Paper 3. 1. Background. 2. Methods
PRODUCT DEVELOPMENT PARTNERSHIPS (PDPS): WORKING TOGETHER: COLLABORATIONS BETWEEN PDPS AND PHARMACEUTICAL BIOTECHNOLOGY COMPANIES BASED IN EMERGING AND DEVELOPING ECONOMIES 1. Background Product Development
More informationPresented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
More informationCan public policy regenerate a traditional industry through collaborative research? The case of the Swedish food industry
Paper to be presented at the DRUID Society Conference 2014, CBS, Copenhagen, June 16-18 Can public policy regenerate a traditional industry through collaborative research? The case of the Swedish food
More informationTHE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
More informationThe Swedish Drug Development Pipeline June 2012. A survey conducted by:
The Swedish Drug Development Pipeline June 2012 A survey conducted by: Key findings More companies report clinical trials There has been a increase in number of companies contributing with information
More informationCorporate Governance Report for Orexo AB (publ)
Corporate Governance Report for Orexo AB (publ) Orexo is a Swedish public limited liability company with registered offices in Uppsala, Sweden. The company s shares are listed on Nasdaq (Mid Cap) Stockholm,
More informationGREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2
GREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2 FINAL VERSION 4/10/2012 Safe and Green Road Vehicles Europe Main and corresponding author: Hans Fogelberg, Region Västra
More informationNational Doctoral Programme in Infections and Antibiotics
Åke Forsberg National Coordinator Anna Holmström National Director of Studies MIMS-affiliated National Doctoral Programme in Infections and Antibiotics (NDPIA) Dept. of Molecular Biology/MIMS Umeå University
More informationBioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover
The rocky way from science to market Dr. Karsten Fischer BioMedPartners AG VPM Days Hannover November 2013 Content I. Stage 1 II. Setbacks 6 III. Hope 12 IV. Solutions 17 V. Expertise 20 Page 1 The Challenge
More informationOpen Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum
Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities
More informationProfile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many
More informationCURRICULUM VITAE (short version)
1 CURRICULUM VITAE (short version) Hans Löfsten, Professor (Chair) Professor, Chair of Engineering Economic Analysis (Teknikens ekonomiska analys), Chalmers University of Technology, Department of Technology
More informationAutomating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
More informationMASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE
University of Cambridge: Programme Specifications Every effort has been made to ensure the accuracy of the information in this programme specification. Programme specifications are produced and then reviewed
More informationVTT Technical Research Centre of Finland 2010
VTT Technical Research Centre of Finland 2010 02/04/2010 2 GDP share of R&D expenditure in Finland % 3 3.43 3.45 3.48 3.45 3.47 3.72 3.92 2.1 1990 1998 2003 2004 2005 2006 2007 2008 2009 Source: Statistics
More informationwww.ivf.se Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild 1 2005-10-24
Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild 1 2005-10-24 IVF Industrial Research and Development Corporation IVF is the Swedish engineering industry's
More informationHCL Healthcare: Meeting Reform Challenges
HCL Healthcare: Meeting Reform Challenges Pradep Nair Senior Vice President Healthcare Practice pnair@hcl.com Agenda Healthcare Industry: Drivers of Change HCL Healthcare Overview Healthcare Sub-Verticals
More informationACC San Diego Chapter
ACC San Diego Chapter Biomedical and Technology Collaborations with Chinese Companies: Legal and Cultural Challenges October 2012 DLA Piper Overview Our Firm 4,200 lawyers in 77 offices and 33 countries
More informationThe Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry
Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge
More informationCONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW
CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams
More informationBiotech Opportunities for Start-Up Firms in Japan and Asia
Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma
More informationBlekinge Institute of Technology. Master Thesis
Blekinge Institute of Technology School of Management Master Thesis Identifying and Ranking of Critical Success Factors for Biotech Startups- An Empirical Study of Biotechnology Firms in Sweden Supervisor:
More informationThe birth of the population-based cohort studies in preventive medicine From Framingham to Värmland
EpiScania Symposium Medicon Village, Lund 2 nd September 2015 The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland Peter M Nilsson, MD, PhD Department of
More informationTaking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset
Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Introduction In this era of strategic development deals, inventiv Health has significantly broadened
More informationNordic Venture Capital:
Menon Publication Nordic Venture Capital: Cross Border Investments MENON-PUBLICATION NO. 20 /2010 Gjermund Grimsby, Leo A. Grünfeld and Anne Espelien www.menon.no PO. Box 5250 Majorstuen N0303 Oslo Tel:
More informationAnalysis of Chain-linked
VINNOVA Analysis VA 2009:20 Analysis of Chain-linked Effects of Public Policy Effects on research and industry in Swedish life sciences within innovative food and medical technology Jens Laage-Hellman,
More informationU.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction
More informationDenmark. Aarhus University. Aalborg University. University of Copenhagen. IT University of Copenhagen. Nordic Techology Transfer Network
Denmark Aarhus University Patent and Contract Department http://www.au.dk/da/adm/led/pke E mail: pke(at)au.dk Tel: +45 89426884 Aalborg University Patent and Contract Department http://patent.aau.dk/ E
More informationLife Sciences Outlook. New Jersey 2015
Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping
More informationA survey conducted by: The Swedish Drug Development Pipeline May 2011
A survey conducted by: The Swedish Drug Development Pipeline May 2011 The survey In February March 2011 a survey of the Swedish Drug Development Pipeline was conducted by SwedenBIO in cooperation with
More informationPRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden
PRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden Contents Many PRT studies & activities in Sweden Mega-study: 15 % higher modal share with PRT Recent PRT studies in
More informationLund LSI. Lund Life Science Incubator Catalyst for growth. Dan J. Mogren Director Business Development
Lund LSI Lund Life Science Incubator Catalyst for growth Lund Life Science Incubator helps entrepreneurs and early companies within life science to develop and commercialize new ideas Dan J. Mogren Director
More informationThe Novo Nordisk Foundation Center for Biosustanability, DTU. Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO.
The Novo Nordisk Foundation Center for Biosustanability, DTU Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO. Center for Biosustainability BIOSUSTAINABILITY: through metabolic
More informationIn the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
More informationDo Swedish property management companies have necessary conditions for environmental management?
Do Swedish property management companies have necessary conditions for environmental management? An interview study on environmental data availability Birgit Brunklaus Environmental Systems Analysis Chalmers
More informationSt. George s University
St. George s University 34-Credit MBA in Multi-Sector Health Management Course Description MGMT 900 Professional Practice: Most individuals in this program will not have an undergraduate business degree.
More informationInternational Council on Systems Engineering. ISO/IEC/IEEE 15288 SEminar Linköping 16 november 2015
International Council on Systems Engineering ISO/IEC/IEEE 15288 SEminar Linköping 16 november 2015 WHY there is a need for SE and INCOSE Need to manage increasing complexity Technology trends Systems of
More informationPhotocure ASA. The world leader in photodynamic technology. Sept 2011. Ketil F. Widerberg, Director Business Development
Brilliance in photodynamic technology Photocure ASA The world leader in photodynamic technology Sept 2011 Ketil F. Widerberg, Director Business Development Photocure Mission Mission To bring innovative
More informationTOPRA 2014 TOPRA IN SWEDEN. Margareth Jorvid TOPRA In Sweden Working Party
TOPRA 2014 TOPRA IN SWEDEN Margareth Jorvid TOPRA In Sweden Working Party ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION Kliniska studier av läkemedel och medicinteknik dagens
More informationEconomic and Social Council
UNITED NATIONS E Economic and Social Council Distr. GENERAL TRANS/SC.2/2003/15 4 August 2003 Original: ENGLISH ECONOMIC COMMISSION FOR EUROPE INLAND TRANSPORT COMMITTEE Working Party on Rail Transport
More informationKnowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, 2016. Copyright 2016 Isis Innovation Ltd.
Knowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, 2016 Mireya McKee Education SI Dip PhD BSc Senior Consultant Mireya McKee 15+ years experience in chemistry,
More information2015 / 2016 Awards Criteria and Submission Information
9 th Annual ViE Awards 2015 / 2016 Awards Criteria and Submission Information In association with: Dear colleague, The Vaccine Industry Excellence (ViE) Awards have been created to honor and generate recognition
More informationAPAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015
APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical
More informationState of the Life Sciences Mergers and Acquisitions Market
State of the Life Sciences Mergers and Acquisitions Market Brian Miller, Managing Partner and Co-Founder, Linden Partners Rich Fante, RF Consulting LLC, Formerly with AstraZeneca Americas Mark Nicholson,
More informationSix Sigma Workshop Fallstudie och praktisk övning
Six Sigma Workshop Fallstudie och praktisk övning 0-fels LEAN-konferens, Folkets Hus 05-NOV-2013 Lars Öst GE business segments Technology Infrastructure Energy Infrastructure GE Capital NBC Universal Healthcare
More informationSWEDEN SWEDEN PHYSICAL ACTIVITY FACTSHEET PREVALENCE (%) OF ADULTS REACHING THE RECOMMENDED PHYSICAL ACTIVITY LEVELS, 2014 ADULTS (16 84 YEARS)*
SWEDEN PHYSICAL ACTIVITY FACTSHEET This is one of the 28 European Union Member States factsheets on health-enhancing physical activity, developed as a part of a joint initiative between the European Commission
More informationBridging Innovation and Business
Otaniemi Incubation Excellence Bridging Innovation and Business Pertti Vuorela, Technopolis Ventures Ltd. Networking Model in Business exploitation Otaniemi High-Tech Area Academic & Research Partners
More informationProgramme Workshop Drug Discovery DDD innova(on: Financing & Re- purposing
Programme Workshop Drug Discovery DDD innova(on: Financing & Re- purposing 09.30-09.40: 09.40-10.00: 10.00-10.30: 10.45-11.30: Welcome and introduc/on (Dr. Cecilia Nilsson, UU Innova/on and Dr. Vendela
More informationA Strategic Innovation Program in Medical Technology
A Strategic Innovation Program in Medical Technology A strategic research and innovation program financed by VINNOVA, Sweden s innovation agency MedTech4Health addresses one of the largest global social
More informationIsraeli Biotechnology Strategy Project. Realizing Our Potential
Israeli Biotechnology Strategy Project *** Realizing Our Potential Final Report Tel Aviv, March 2001 Submitted to The Chief Scientist, Ministry of Industry and Trade The Ministry of Finance The IBO by
More informationSUMMER COURSES 2012 Nordic Centre at Fudan University. Doing Business in China Introduction to Modern China
SUMMER COURSES 2012 Nordic Centre at Fudan University Doing Business in China Introduction to Modern China 欢 迎 WELCOME to the 2012 Summer Courses at Nordic Centre, Fudan University! The Nordic Centre Summer
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationBioForum 2012 Central European Forum of Biotechnology and Innovative BioEconomy 23rd-24th May 2012, Brno Date & Venue Date Venue
BioForum 2012 Central European Forum of Biotechnology and Innovative BioEconomy 23 rd -24 th May 2012, Brno www.cebioforum.com Author: Edyta Wodzińska Bio-Tech Consulting 1 Date & Venue Date: May 23 rd
More informationThe Commercialization of Technology Concepts into Medical Products
The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community
More informationYear-end report 2006 Prevas AB (publ), corporate reg. no. 556252-1384
Year-end report 2006 Prevas AB (publ), corporate reg. no. 556252-1384 Continued successful growth order intake increased by 69 percent in the fourth quarter SUMMARY (MSEK) 2006 2005 Q4 2006 Q4 2005 Net
More informationVIRGINIA SMALL BUSINESS FINANCING AUTHORITY
VIRGINIA SMALL BUSINESS FINANCING AUTHORITY PRESENTATION TO THE HOUSE APPROPRIATIONS COMMITTEE Virginia House of Delegates January 24, 2011 Department of Business Assistance Department of Business Assistance
More informationProfile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Boston Along with San Francisco,
More informationStrategic Innovation Agenda for Smart Sustainable Cities. Urban living lab, 25 May 2016 Olga Kordas
Strategic Innovation Agenda for Smart Sustainable Cities Urban living lab, 25 May 201 Olga Kordas The concept of smart sustainable cities Cloud Mobility Broadband Smart solutions e-services Integrated
More informationGröna Tåget [grœ:na 'tɔ:gɛt] to make train travel more attractive
Gröna Tåget [grœ:na 'tɔ:gɛt] to make train travel more attractive Oskar Fröidh Royal Institute of Technology (KTH) Stockholm, January 25, 2012 What are specific Nordic conditions? Harsh winters Elks and
More informationAn Introduction to Packbridge
An Introduction to Packbridge Per-Stefan Gersbro Nätverksträff Flextrus, 7 februari 2012 Picture: Tetra Pak The most efficient way to make a package! Tetra Pak - 1952 A good package should save more than
More informationBayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
More informationRETAIL MARKET IN SWEDEN
RETAIL MARKET IN SWEDEN SECTOR OVERVIEW Opportunities in a retail growth market 1 SWEDEN IDEAL MARKET FOR INTERNATIONAL RETAILERS SECTOR OVERVIEW WHY SWEDEN? Top-performing and growing economy Steady population
More informationActive Biotech Group Interim Report 1 January 30 September 1999
Active Biotech Group Interim Report 1 January 30 September 1999 The new annual forecast shows a considerably better result. Sale of the property in Solna expected to be completed before the end of the
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationUniversities, Patents and Innovation: What s in it for the entrepreneur?
Universities, Patents and Innovation: What s in it for the entrepreneur? Professor Maureen McKelvey Director of Research Institute of Innovation & Entrepreneurship University of Gothenburg Entrepreneurs
More informationInvestor Growth Capital Stephen Campe
Investor Growth Capital Stephen Campe Head of Investor Growth Capital Agenda 1. Rationale for Investor Growth Capital and strategy 2. Business overview and setup 3. Our value creation model 4. The portfolio
More informationOPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY
NINESIGMA WHITE PAPER OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY How six leading healthcare companies are leveraging Open Innovation to achieve their innovation goals By: Stephen Clulow, Director
More informationJune 2016. Marcus Holgersson. Page 1 of 5
Page 1 of 5 CV CURRICULUM Name: Nationality: Place of residence: VITAE June 2016 Marcus Holgersson Swedish Gothenburg, Sweden Academic degrees 2012 PhD from Chalmers University of Technology: Technology
More informationOFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION
OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION Where is Pennsylvania? PA is located within 500 miles of: 40% of the U.S. population
More information